VICENTE ANIDO JR Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for VICENTE ANIDO JR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of VICENTE ANIDO JR. VICENTE ANIDO JR is Director in DEPOMED INC ($DMI) and President & CEO in ISTA PHARMACEUTICALS INC ($ISTA) and Chief Executive Officer in AERIE PHARMACEUTICALS INC ($AERI).
Latest Insider Trading Transactions of VICENTE ANIDO JR
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AERI, DMI, ISTA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 25 2021 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 15.66 | 1,700 | 26,622 | 233,396 | 235.1 K to 233.4 K (-0.72 %) |
| Feb 09 2021 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 17.72 | 2,500 | 44,300 | 235,096 | 237.6 K to 235.1 K (-1.05 %) |
| Feb 09 2021 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 17.68 | 2,496 | 44,129 | 237,596 | 240.1 K to 237.6 K (-1.04 %) |
| Feb 09 2021 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 17.68 | 2,958 | 52,297 | 240,092 | 243.1 K to 240.1 K (-1.22 %) |
| Feb 08 2021 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Option Exercise | A | 17.64 | 125,000 | 2,205,000 | 125,000 | |
| Feb 08 2021 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Grant | A | 0.00 | 28,000 | 0 | 243,050 | 215.1 K to 243.1 K (+13.02 %) |
| May 18 2020 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 14.85 | 4,746 | 70,454 | 215,050 | 219.8 K to 215.1 K (-2.16 %) |
| Feb 25 2020 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 20.30 | 1,527 | 30,998 | 219,796 | 221.3 K to 219.8 K (-0.69 %) |
| Feb 25 2020 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 21.59 | 1,052 | 22,713 | 221,323 | 222.4 K to 221.3 K (-0.47 %) |
| Feb 11 2020 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 20.49 | 1,546 | 31,678 | 222,375 | 223.9 K to 222.4 K (-0.69 %) |
| Feb 11 2020 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 20.49 | 1,710 | 35,038 | 223,921 | 225.6 K to 223.9 K (-0.76 %) |
| Feb 10 2020 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Option Exercise | A | 21.18 | 125,000 | 2,647,500 | 125,000 | |
| Feb 10 2020 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Grant | A | 0.00 | 28,000 | 0 | 225,631 | 197.6 K to 225.6 K (+14.17 %) |
| Feb 10 2020 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Buy | W | 0.00 | 2,250 | 0 | 10,500 | 8.3 K to 10.5 K (+27.27 %) |
| Sep 09 2019 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Buy | P | 19.95 | 2,000 | 39,900 | 197,631 | 195.6 K to 197.6 K (+1.02 %) |
| Sep 09 2019 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Buy | P | 18.93 | 24,250 | 459,053 | 195,631 | 171.4 K to 195.6 K (+14.15 %) |
| May 17 2019 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 40.54 | 4,145 | 168,038 | 171,381 | 175.5 K to 171.4 K (-2.36 %) |
| May 17 2019 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Grant | A | 0.00 | 32,171 | 0 | 175,526 | 143.4 K to 175.5 K (+22.44 %) |
| Apr 15 2019 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 41.89 | 2,612 | 109,417 | 143,355 | 146 K to 143.4 K (-1.79 %) |
| Feb 11 2019 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Option Exercise | A | 43.07 | 114,358 | 4,925,399 | 114,358 | |
| Feb 11 2019 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 40.39 | 1,624 | 65,593 | 150,109 | 151.7 K to 150.1 K (-1.07 %) |
| Feb 11 2019 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Grant | A | 0.00 | 25,413 | 0 | 151,733 | 126.3 K to 151.7 K (+20.12 %) |
| Jun 13 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Option Exercise | M | 3.15 | 50,000 | 157,500 | 846,329 | |
| Jun 13 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Sell | S | 62.92 | 4,996 | 314,350 | 126,320 | 131.3 K to 126.3 K (-3.80 %) |
| Jun 13 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Sell | S | 61.90 | 45,004 | 2,785,946 | 131,316 | 176.3 K to 131.3 K (-25.52 %) |
| Jun 13 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Buy | M | 3.15 | 50,000 | 157,500 | 176,320 | 126.3 K to 176.3 K (+39.58 %) |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Option Exercise | M | 3.15 | 26,139 | 82,338 | 896,329 | |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Option Exercise | M | 2.90 | 23,861 | 69,197 | 0 | |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Option Exercise | M | 2.90 | 50,000 | 145,000 | 23,861 | |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Option Exercise | M | 2.90 | 50,000 | 145,000 | 73,861 | |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Sell | S | 64.52 | 29,717 | 1,917,362 | 126,320 | 156 K to 126.3 K (-19.04 %) |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Sell | S | 63.35 | 20,283 | 1,284,924 | 156,037 | 176.3 K to 156 K (-11.50 %) |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Buy | M | 3.15 | 26,139 | 82,338 | 176,320 | 150.2 K to 176.3 K (+17.40 %) |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Buy | M | 2.90 | 23,861 | 69,197 | 150,181 | 126.3 K to 150.2 K (+18.89 %) |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Sell | S | 62.80 | 16,386 | 1,029,092 | 126,320 | 142.7 K to 126.3 K (-11.48 %) |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Sell | S | 62.06 | 33,614 | 2,085,957 | 142,706 | 176.3 K to 142.7 K (-19.06 %) |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Buy | M | 2.90 | 50,000 | 145,000 | 176,320 | 126.3 K to 176.3 K (+39.58 %) |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Sell | S | 61.10 | 4,338 | 265,044 | 126,320 | 130.7 K to 126.3 K (-3.32 %) |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Sell | S | 60.44 | 45,662 | 2,760,003 | 130,658 | 176.3 K to 130.7 K (-25.90 %) |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Buy | M | 2.90 | 50,000 | 145,000 | 176,320 | 126.3 K to 176.3 K (+39.58 %) |
| May 10 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 53.85 | 1,351 | 72,751 | 126,320 | 127.7 K to 126.3 K (-1.06 %) |
| May 10 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 53.85 | 2,054 | 110,608 | 127,671 | 129.7 K to 127.7 K (-1.58 %) |
| May 10 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 53.85 | 1,052 | 56,650 | 129,725 | 130.8 K to 129.7 K (-0.80 %) |
| Apr 16 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 53.40 | 3,149 | 168,157 | 130,777 | 133.9 K to 130.8 K (-2.35 %) |
| Apr 16 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Grant | A | 0.00 | 21,448 | 0 | 133,926 | 112.5 K to 133.9 K (+19.07 %) |
| Feb 12 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Option Exercise | A | 53.55 | 114,358 | 6,123,871 | 114,358 | |
| Feb 12 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Grant | A | 0.00 | 25,413 | 0 | 112,478 | 87.1 K to 112.5 K (+29.19 %) |
| Feb 27 2017 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Option Exercise | A | 44.25 | 155,528 | 6,882,114 | 155,528 | |
| Feb 27 2017 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 44.55 | 1,518 | 67,627 | 87,065 | 88.6 K to 87.1 K (-1.71 %) |
| Feb 27 2017 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 44.55 | 1,716 | 76,448 | 88,583 | 90.3 K to 88.6 K (-1.90 %) |
| Feb 27 2017 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Grant | A | 0.00 | 17,281 | 0 | 90,299 | 73 K to 90.3 K (+23.67 %) |
| May 13 2016 | DMI | DEPOMED INC | ANIDO VICENTE JR | Director | Payment of Exercise | F | 17.52 | 1,035 | 18,133 | 4,403 | 5.4 K to 4.4 K (-19.03 %) |
| Mar 01 2016 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Option Exercise | A | 16.69 | 150,504 | 2,511,912 | 150,504 | |
| Mar 01 2016 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Grant | A | 0.00 | 25,085 | 0 | 75,273 | 50.2 K to 75.3 K (+49.98 %) |
| Dec 03 2015 | DMI | DEPOMED INC | ANIDO VICENTE JR | Director | Payment of Exercise | F | 19.00 | 1,361 | 25,859 | 2,502 | 3.9 K to 2.5 K (-35.23 %) |
| May 13 2015 | DMI | DEPOMED INC | ANIDO VICENTE JR | Director | Option Exercise | A | 0.00 | 2,936 | 0 | 2,936 | |
| May 13 2015 | DMI | DEPOMED INC | ANIDO VICENTE JR | Director | Option Exercise | A | 20.43 | 7,857 | 160,519 | 7,857 | |
| Feb 27 2015 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Option Exercise | A | 28.03 | 133,125 | 3,731,494 | 133,125 | |
| Feb 27 2015 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Grant | A | 0.00 | 22,188 | 0 | 50,188 | 28 K to 50.2 K (+79.24 %) |
| Feb 18 2010 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Sell | D | 3.96 | 1,705 | 6,752 | 415,067 | 416.8 K to 415.1 K (-0.41 %) |
| Feb 10 2010 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Sell | D | 3.59 | 3,332 | 11,962 | 416,772 | 420.1 K to 416.8 K (-0.79 %) |
| Feb 05 2010 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Sell | D | 3.60 | 3,995 | 14,382 | 420,104 | 424.1 K to 420.1 K (-0.94 %) |
| Feb 04 2010 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Option Exercise | A | 3.63 | 123,789 | 449,354 | 123,789 | |
| Feb 04 2010 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Option Exercise | A | 3.63 | 39,861 | 144,695 | 39,861 | |
| Feb 04 2010 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Grant | A | 0.00 | 36,350 | 36 | 424,099 | 387.7 K to 424.1 K (+9.37 %) |
| Feb 04 2010 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Sell | D | 3.63 | 2,286 | 8,298 | 387,749 | 390 K to 387.7 K (-0.59 %) |
| Feb 27 2009 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Buy | P | 1.97 | 10,000 | 19,700 | 390,035 | 380 K to 390 K (+2.63 %) |
| Feb 27 2009 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Buy | P | 1.99 | 17,500 | 34,825 | 380,035 | 362.5 K to 380 K (+4.83 %) |
| Feb 27 2009 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Buy | P | 1.97 | 3,444 | 6,785 | 362,535 | 359.1 K to 362.5 K (+0.96 %) |
| Feb 26 2009 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Buy | P | 1.99 | 12,296 | 24,469 | 359,091 | 346.8 K to 359.1 K (+3.55 %) |
| Feb 26 2009 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Buy | P | 1.85 | 18,579 | 34,297 | 346,795 | 328.2 K to 346.8 K (+5.66 %) |
| Feb 26 2009 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Buy | P | 2.01 | 20,000 | 40,200 | 328,216 | 308.2 K to 328.2 K (+6.49 %) |
| Feb 05 2009 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Option Exercise | A | 1.04 | 115,914 | 120,551 | 115,914 | |
| Feb 05 2009 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Option Exercise | A | 1.04 | 47,736 | 49,645 | 47,736 | |
| Feb 05 2009 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Grant | A | 0.00 | 36,350 | 36 | 308,216 | 271.9 K to 308.2 K (+13.37 %) |
| Dec 12 2008 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Buy | P | 0.84 | 7,550 | 6,353 | 253,266 | 245.7 K to 253.3 K (+3.07 %) |
| Dec 12 2008 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Buy | P | 0.99 | 83,000 | 82,253 | 245,716 | 162.7 K to 245.7 K (+51.01 %) |
| Dec 11 2008 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Buy | P | 0.75 | 8,000 | 6,000 | 162,716 | 154.7 K to 162.7 K (+5.17 %) |
| Dec 11 2008 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Buy | P | 0.66 | 22,712 | 14,954 | 154,716 | 132 K to 154.7 K (+17.21 %) |
| Dec 11 2008 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Buy | P | 0.67 | 67,100 | 45,252 | 132,004 | 64.9 K to 132 K (+103.38 %) |
| Feb 20 2008 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Payment of Exercise | F | 4.56 | 1,662 | 7,579 | 65,054 | 66.7 K to 65.1 K (-2.49 %) |
| Feb 12 2008 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Option Exercise | A | 4.46 | 140,906 | 628,441 | 140,906 | |
| Feb 12 2008 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Option Exercise | A | 4.46 | 22,744 | 101,438 | 22,744 | |
| Feb 12 2008 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Grant | A | 0.00 | 36,500 | 37 | 66,716 | 30.2 K to 66.7 K (+120.80 %) |
| Feb 05 2008 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Payment of Exercise | F | 5.27 | 2,222 | 11,710 | 30,216 | 32.4 K to 30.2 K (-6.85 %) |
| Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Option Exercise | A | 7.43 | 81,185 | 603,205 | 81,185 | |
| Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Option Exercise | A | 6.77 | 116,046 | 785,631 | 116,046 | |
| Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Option Exercise | A | 7.43 | 12,415 | 92,243 | 12,415 | |
| Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Option Exercise | A | 6.77 | 14,154 | 95,823 | 14,154 | |
| Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Sell | D | 8.11 | 1,662 | 13,479 | 32,438 | 34.1 K to 32.4 K (-4.87 %) |
| Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Grant | A | 0.00 | 20,800 | 21 | 34,100 | 13.3 K to 34.1 K (+156.39 %) |
| Feb 21 2006 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Option Exercise | A | 6.77 | 130,200 | 881,454 | 130,200 | |
| Feb 21 2006 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Grant | A | 0.00 | 18,600 | 19 | 31,900 | 13.3 K to 31.9 K (+139.85 %) |
| May 13 2005 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Buy | P | 7.58 | 192 | 1,455 | 13,300 | 13.1 K to 13.3 K (+1.46 %) |
| May 13 2005 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Buy | P | 7.59 | 908 | 6,892 | 13,108 | 12.2 K to 13.1 K (+7.44 %) |
| May 13 2005 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Buy | P | 7.57 | 300 | 2,271 | 12,200 | 11.9 K to 12.2 K (+2.52 %) |
| May 13 2005 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Buy | P | 7.60 | 400 | 3,040 | 11,900 | 11.5 K to 11.9 K (+3.48 %) |
| May 13 2005 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Buy | P | 7.62 | 400 | 3,048 | 11,500 | 11.1 K to 11.5 K (+3.60 %) |
| May 13 2005 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Buy | P | 7.69 | 100 | 769 | 11,100 | 11 K to 11.1 K (+0.91 %) |
| May 13 2005 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Buy | P | 7.66 | 200 | 1,532 | 11,000 | 10.8 K to 11 K (+1.85 %) |
| May 13 2005 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Buy | P | 7.60 | 2,300 | 17,480 | 10,800 | 8.5 K to 10.8 K (+27.06 %) |
| May 13 2005 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Buy | P | 7.59 | 4,669 | 35,438 | 8,500 | 3.8 K to 8.5 K (+121.87 %) |
| May 13 2005 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Buy | P | 7.58 | 300 | 2,274 | 3,831 | 3.5 K to 3.8 K (+8.50 %) |
| May 13 2005 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Buy | P | 7.70 | 3,531 | 27,189 | 3,531 | 0 to 3.5 K |
| Feb 18 2005 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Option Exercise | A | 10.27 | 85,240 | 875,415 | 85,240 | |
| Feb 18 2005 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Option Exercise | A | 10.27 | 10,361 | 106,407 | 10,361 | |
| Jul 26 2004 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Option Exercise | A | 20.00 | 100,461 | 2,009,220 | 100,461 | |
| Jul 26 2004 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Option Exercise | A | 9.41 | 49,798 | 468,599 | 49,798 | |
| Jul 26 2004 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Option Exercise | A | 3.49 | 566,347 | 1,976,551 | 566,347 | |
| Jul 26 2004 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Option Exercise | A | 9.41 | 38,202 | 359,481 | 38,202 | |
| Jul 26 2004 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Option Exercise | A | 3.49 | 28,653 | 99,999 | 28,653 |
Page: 1